Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Valvular Heart Disease

Free Subscription Articles published in Heart Retrieve available abstracts of 183 articles: HTML format

Single Articles

August 2026
1. SUN Y, Tong Q, Qian Y
   Severe eccentric mitral regurgitation with echocardiography moving in a flail motion.
   Heart. 2026;112:991-992.
   PubMed    
   
   
   
2. HONG N, Chen L, Liu XB, Wang J, et al
   Ascending aorta and pure aortic regurgitation transcatheter aortic valve replacement: insights from the National Transcatheter Valve Therapeutics Registry.
   Heart. 2026 Aug 7:heartjnl-2025-327742. doi: 10.1136/heartjnl-2025-327742.
   PubMed     Abstract available
   
   
   July 2026
3. BEARPARK L, Dismorr M, Franco-Cereceda A, Sartipy U, et al
   Survival following aortic valve surgery for prosthetic valve endocarditis: a SWEDEHEART study.
   Heart. 2026 Jul 30:heartjnl-2026-327973. doi: 10.1136/heartjnl-2026-327973.
   PubMed     Abstract available
   
   
   
4. FRIEDERICY HJ, Lustig MJ, de Haes FI, van der Kley F, et al
   Comparative environmental life cycle assessment between transfemoral transcatheter aortic valve implantation and isolated surgical aortic valve replacement.
   Heart. 2026 Jul 29:heartjnl-2026-328011. doi: 10.1136/heartjnl-2026-328011.
   PubMed     Abstract available
   
   
   
5. MIRZOHREH ST, Deravi N, Javanshir E, Asghari Jafarabadi M, et al
   Impact of diabetes on outcomes in hypertrophic cardiomyopathy: a GRADE meta-analysis.
   Heart. 2026;112:876-888.
   PubMed     Abstract available
   
   
   
6. LI B, Wei X, Chen M
   Atypical respiratory variation: trace to massive tricuspid regurgitation.
   Heart. 2026;112:933-934.
   PubMed    
   
   
   
7. FAGGIANO P, Gamberini G, Otto CM
   From natural to unnatural history of aortic valve stenosis: a tribute to Dr Braunwald's legacy.
   Heart. 2026 Jul 10:heartjnl-2026-328534. doi: 10.1136/heartjnl-2026-328534.
   PubMed    
   
   
   
8. SIA CH, Kong WKF
   Refining evidence-based care for diverse bicuspid aortic valve phenotypes: addressing one piece of a larger puzzle.
   Heart. 2026 Jul 6:heartjnl-2026-328293. doi: 10.1136/heartjnl-2026-328293.
   PubMed    
   
   
   June 2026
9. OKUNO T, Gatuz MV
   Stroke after transcatheter aortic valve implantation: the limits of progress.
   Heart. 2026 Jun 11:heartjnl-2026-328363. doi: 10.1136/heartjnl-2026-328363.
   PubMed    
   
   
   
10. BERNARD A
    Aortic stenosis in patients with heart failure: anything but benign.
    Heart. 2026 Jun 2:heartjnl-2025-327713. doi: 10.1136/heartjnl-2025-327713.
    PubMed    
    
    
    May 2026
11. HSIAO Y, Hung KH, Yeh CF, Chen YH, et al
    Generalisable artificial intelligence ECG trained on public data for outcome prediction after transcatheter aortic valve replacement.
    Heart. 2026 May 28:heartjnl-2025-327462. doi: 10.1136/heartjnl-2025-327462.
    PubMed     Abstract available
    
    
    
12. SHAO R, Huang FY, Liao Y, Li YM, et al
    Effect of renin-angiotensin system inhibition on left ventricular mass regression after transcatheter aortic valve replacement: a randomised controlled trial.
    Heart. 2026 May 28:heartjnl-2025-326803. doi: 10.1136/heartjnl-2025-326803.
    PubMed     Abstract available
    
    
    
13. BOLETI O, Sunjaya A, Field E, Norrish G, et al
    Characterisation and prognostic implications of the 12-lead electrocardiogram in children with RASopathy-associated hypertrophic cardiomyopathy.
    Heart. 2026;112:692-696.
    PubMed     Abstract available
    
    
    
14. HU X, Ye Y, Li Z, Liu QR, et al
    Ambient fine particulate matter exposure and prognosis in patients with valvular heart disease.
    Heart. 2026 May 18:heartjnl-2025-327619. doi: 10.1136/heartjnl-2025-327619.
    PubMed     Abstract available
    
    
    
15. SHELBAYA K, Shah AM
    Personalised surveillance for aortic stenosis progression: a work in progress.
    Heart. 2026 May 17:heartjnl-2026-328153. doi: 10.1136/heartjnl-2026-328153.
    PubMed    
    
    
    
16. FLATHER M, Shibata MC
    Transcatheter aortic valve replacement in low-to-medium surgical risk patients: time for a reappraisal?
    Heart. 2026 May 17:heartjnl-2026-327943. doi: 10.1136/heartjnl-2026-327943.
    PubMed    
    
    
    
17. LOUCA A, Petursson P, Sundstrom J, Hagstrom H, et al
    Stroke after transcatheter aortic valve implantation: incidence, temporal trends and predictors.
    Heart. 2026 May 14:heartjnl-2025-327547. doi: 10.1136/heartjnl-2025-327547.
    PubMed     Abstract available
    
    
    
18. MARIN-CUARTAS M, Borger MA, Heuts S
    Practical applicability of life expectancy and age in the decision to perform transcatheter or surgical aortic valve replacement.
    Heart. 2026 May 8:heartjnl-2026-328214. doi: 10.1136/heartjnl-2026-328214.
    PubMed    
    
    
    
19. IELASI A, Moscarella E, Barki M, Caminiti R, et al
    Global variability in bicuspid aortic valve morphology and aortopathy among patients with severe aortic stenosis referred for transcatheter valve implantation.
    Heart. 2026 May 4:heartjnl-2025-327445. doi: 10.1136/heartjnl-2025-327445.
    PubMed     Abstract available
    
    
    April 2026
20. NAGELE F, Gollmann-Tepekoylu C, Splika J, Hofer D, et al
    Artificial chords in endoscopic mitral valve repair: a comparative analysis of surgical techniques and long-term outcomes.
    Heart. 2026 Apr 20:heartjnl-2026-327812. doi: 10.1136/heartjnl-2026-327812.
    PubMed     Abstract available
    
    
    
21. ALLAM M, Villa Etchegoyen C, Alsidawi S, Pathangey G, et al
    Prognostic value of transaortic flow rate compared with ejection fraction and stroke volume index in low-gradient severe aortic stenosis.
    Heart. 2026 Apr 14:heartjnl-2025-327594. doi: 10.1136/heartjnl-2025-327594.
    PubMed     Abstract available
    
    
    
22. LEE MS, Zhou M, Ho M, Wu YL, et al
    Risk factor profiles and haemodynamic progression in aortic stenosis: a retrospective population-based study.
    Heart. 2026 Apr 10:heartjnl-2025-327243. doi: 10.1136/heartjnl-2025-327243.
    PubMed     Abstract available
    
    
    
23. BRAVER J, Marwick TH, Nolan J, Petitjean C, et al
    Cardiac rehabilitation after transcatheter aortic valve implantation before, during and after the COVID-19 pandemic: a whole-population study.
    Heart. 2026 Apr 3:heartjnl-2025-327186. doi: 10.1136/heartjnl-2025-327186.
    PubMed     Abstract available
    
    
    
24. USEINI D, Kutschka I, Baraki H
    Correspondence on 'Updated 5-year outcomes of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low- to intermediate-surgical risk', by Marin-Cuartas et al.
    Heart. 2026 Apr 3:heartjnl-2026-328122. doi: 10.1136/heartjnl-2026-328122.
    PubMed    
    
    
    March 2026
25. MASILAMANI MSJ, Raj V, Raj S
    Adolescent male with aortic valve mass.
    Heart. 2026;112:467-468.
    PubMed    
    
    
    
26. TREVIS J, Cheong J, Wilkinson C, Ogundimu E, et al
    Mechanical versus biological aortic valve replacement in patients aged 50-70 years: a systematic review and meta-analysis.
    Heart. 2026 Mar 18:heartjnl-2025-327763. doi: 10.1136/heartjnl-2025-327763.
    PubMed     Abstract available
    
    
    
27. BUTCHER SC, Lewin S, Budgeon CA, Walker J, et al
    Life expectancy and determinants of relative survival following surgical aortic valve replacement for aortic stenosis.
    Heart. 2026 Mar 18:heartjnl-2025-327029. doi: 10.1136/heartjnl-2025-327029.
    PubMed     Abstract available
    
    
    
28. YADAV S, Bansal D, V B, Kumar S, et al
    Rare cardiac outpouching in rheumatic mitral valve disease.
    Heart. 2026;112:409-410.
    PubMed    
    
    
    
29. BAAY M, Hosseini Z, Zadgari E, Moayerifar M, et al
    Impact of advanced cardiac damage in severe aortic stenosis on short-term and mid-term mortality and rehospitalisation after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Heart. 2026 Mar 6:heartjnl-2025-326941. doi: 10.1136/heartjnl-2025-326941.
    PubMed     Abstract available
    
    
    February 2026
30. SCHOONVELDE SAC, Zwetsloot PP, Hirsch A, Schinkel AFL, et al
    Accelerometry-defined physical activity and quality of life in hypertrophic cardiomyopathy.
    Heart. 2026;112:333-340.
    PubMed     Abstract available
    
    
    
31. LOKESH N, Kannarkat JT, Reardon MJ
    Assessing transcatheter tricuspid valve replacement: evidence, viability and adoption.
    Heart. 2026 Feb 16:heartjnl-2025-327129. doi: 10.1136/heartjnl-2025-327129.
    PubMed    
    
    
    
32. MARIN-CUARTAS M, Kawczynski MJ, de Waha S, Kiefer P, et al
    Updated 5-year outcomes of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low- to intermediate-surgical risk.
    Heart. 2026 Feb 11:heartjnl-2025-327092. doi: 10.1136/heartjnl-2025-327092.
    PubMed     Abstract available
    
    
    January 2026
33. ADELI A, Swahn E, Lind L, Soderberg S, et al
    Sex differences in the prevalence and risk factors for aortic valve calcification in the general population.
    Heart. 2026 Jan 29:heartjnl-2025-326468. doi: 10.1136/heartjnl-2025-326468.
    PubMed     Abstract available
    
    
    
34. HEITZINGER G, Torrefranca CS, Koschatko S, Jantsch C, et al
    Impact and prognostic implications of aortic stenosis across the heart failure spectrum: a cohort study.
    Heart. 2026 Jan 21:heartjnl-2025-326808. doi: 10.1136/heartjnl-2025-326808.
    PubMed     Abstract available
    
    
    
35. YOON J, Liabot Q, Jamieson C, MacLeod B, et al
    Transcatheter aortic valve degeneration: a combined clinical and translational perspective.
    Heart. 2026 Jan 19:heartjnl-2025-326405. doi: 10.1136/heartjnl-2025-326405.
    PubMed     Abstract available
    
    
    
36. KASPRZAK JD
    Progression of valvular heart disease: an academic concept or a clinical imperative?
    Heart. 2026 Jan 12:heartjnl-2025-327550. doi: 10.1136/heartjnl-2025-327550.
    PubMed    
    
    
    December 2025
37. ZHOU Z, Zheng Y, Hu S, Xu J, et al
    Multisystem comorbidities and shared genetic pathways in calcific aortic stenosis: a phenome-wide and Mendelian randomisation analysis.
    Heart. 2025 Dec 29:heartjnl-2025-326058. doi: 10.1136/heartjnl-2025-326058.
    PubMed     Abstract available
    
    
    
38. DAVIDSEN AH, Andersen S, Halvorsen PA, Aviles Solis JC, et al
    Heart murmurs in the general population: diagnostic value and prevalence from the Tromso Study.
    Heart. 2025;112:103-110.
    PubMed     Abstract available
    
    
    
39. CHEN M, Sahiti F, Cejka V, Schmidbauer L, et al
    Frequency and natural course of American College of Cardiology/American Heart Association valvular heart disease stages in the general population: results from the population-based STAAB cohort study.
    Heart. 2025 Dec 9:heartjnl-2025-326443. doi: 10.1136/heartjnl-2025-326443.
    PubMed     Abstract available
    
    
    November 2025
40. CHEN M, Yue Z, Xu L, Fan P, et al
    Prosthetic annulus size mismatch and recurrent mitral regurgitation after repair in advanced degenerative disease.
    Heart. 2025 Nov 30:heartjnl-2025-325968. doi: 10.1136/heartjnl-2025-325968.
    PubMed     Abstract available
    
    
    
41. MALAHFJI M
    Natural history of aortic regurgitation in the contemporary era: not so benign.
    Heart. 2025 Nov 24:heartjnl-2025-327335. doi: 10.1136/heartjnl-2025-327335.
    PubMed    
    
    
    
42. NASER JA, Massad F, Al-Abcha A, Gerberi D, et al
    Natural history of asymptomatic moderate or severe aortic regurgitation: a systematic review and meta-analysis.
    Heart. 2025 Nov 17:heartjnl-2025-326643. doi: 10.1136/heartjnl-2025-326643.
    PubMed     Abstract available
    
    
    
43. SALIHU A, Antiochos P, Lu H, Maurizi N, et al
    Association between programmed electrical stimulation inducibility and arrhythmic risk in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Heart. 2025;111:1135-1140.
    PubMed     Abstract available
    
    
    
44. ABDALWAHAB A, Das R, Alkhalil M
    Inferior ST-segment elevation during transcatheter aortic valve implantation.
    Heart. 2025;111:1167-1168.
    PubMed    
    
    
    October 2025
45. VAN WIJNGAARDEN AL, de Riva M, Sabbag A, El-Am E, et al
    Ventricular arrhythmias during exercise in patients with mitral valve prolapse.
    Heart. 2025 Oct 20:heartjnl-2025-326395. doi: 10.1136/heartjnl-2025-326395.
    PubMed     Abstract available
    
    
    
46. LOVE CJ, Lampert J, Huneycutt D, Musat DL, et al
    Clinical implementation of an AI-enabled ECG for hypertrophic cardiomyopathy detection.
    Heart. 2025;111:1029-1035.
    PubMed     Abstract available
    
    
    September 2025
47. WANG H, Li J, Hsi DH, Li W, et al
    Percutaneous intramyocardial septal radiofrequency ablation: a novel treatment for drug-refractory non-obstructive hypertrophic cardiomyopathy with severe septal hypertrophy.
    Heart. 2025;111:933-940.
    PubMed     Abstract available
    
    
    
48. NISHIURA N, Kubo S, Ono S, Mushiake K, et al
    Prognostic value of leaflet coaptation gap in transcatheter edge-to-edge repair for functional mitral regurgitation.
    Heart. 2025 Sep 8:heartjnl-2024-325585. doi: 10.1136/heartjnl-2024-325585.
    PubMed     Abstract available
    
    
    
49. JIA S, Liu P, Wang M, Zhong X, et al
    Midterm outcomes of rheumatic mitral valve repair versus replacement in a dual-centre retrospective study.
    Heart. 2025 Sep 5:heartjnl-2025-326323. doi: 10.1136/heartjnl-2025-326323.
    PubMed     Abstract available
    
    
    August 2025
50. KUBO T, Sugiura K, Tokita Y, Takano H, et al
    Contemporary clinical characteristics and management patterns in hypertrophic cardiomyopathy: insights from baseline enrolment data in a nationwide prospective Japanese registry.
    Heart. 2025;111:885-892.
    PubMed     Abstract available
    
    
    
51. WANG Z, Qian X, Lv J, Li Z, et al
    Asthma and risk of degenerative valvular heart disease: a prospective cohort study.
    Heart. 2025 Aug 19:heartjnl-2024-325575. doi: 10.1136/heartjnl-2024-325575.
    PubMed     Abstract available
    
    
    
52. CAO D, Sandri M, Garot P, Pelliccia F, et al
    Prevalence and prognostic implications of the Valve Academic Research Consortium-High Bleeding Risk criteria in patients undergoing transcatheter aortic valve implantation.
    Heart. 2025 Aug 12:heartjnl-2025-326043. doi: 10.1136/heartjnl-2025-326043.
    PubMed     Abstract available
    
    
    
53. TSURUMI H, Kusunose K
    Atrial fibrillation in chronic aortic regurgitation: the missing link in prognosis and surgical timing.
    Heart. 2025 Aug 11:heartjnl-2025-326727. doi: 10.1136/heartjnl-2025-326727.
    PubMed    
    
    
    
54. BARBOSA GS, Katsuyama ES, Fukunaga CK, Fernandes JM, et al
    Surgical ablation in non-mitral valve cardiac surgeries: a meta-analysis of early outcomes.
    Heart. 2025 Aug 7:heartjnl-2025-326299. doi: 10.1136/heartjnl-2025-326299.
    PubMed     Abstract available
    
    
    
55. XIANG H, Zhang Y, Zhang Y, Ye Z, et al
    Plasma metabolomics uncovers key metabolites and enhances prediction of aortic stenosis: insights from prospective cohort and Mendelian randomisation studies.
    Heart. 2025 Aug 4:heartjnl-2025-326161. doi: 10.1136/heartjnl-2025-326161.
    PubMed     Abstract available
    
    
    July 2025
56. BHARUCHA AH, Brown S, Theofilatos K, Singh B, et al
    Parsimonious machine learning model to predict 1-year mortality and procedural futility after transcatheter aortic valve replacement.
    Heart. 2025 Jul 25:heartjnl-2025-325928. doi: 10.1136/heartjnl-2025-325928.
    PubMed     Abstract available
    
    
    
57. MATTIG I, Romero Dorta E, Frumkin D, Kretzschmar H, et al
    Sex differences in the prevalence and prognosis of tricuspid regurgitation among patients with heart failure.
    Heart. 2025 Jul 24:heartjnl-2025-325913. doi: 10.1136/heartjnl-2025-325913.
    PubMed     Abstract available
    
    
    
58. CHANG CJ, Chi NH, Wu CH, Huang LY, et al
    Comparative evaluation of biological and mechanical prostheses for aortic valve replacement in a middle-aged population: a population-based cohort study.
    Heart. 2025 Jul 16:heartjnl-2024-325648. doi: 10.1136/heartjnl-2024-325648.
    PubMed     Abstract available
    
    
    
59. PUGLIESI GM, Scott CG, Nkomo VT, Michelena HI, et al
    Prevalence and prognostic role of atrial fibrillation in chronic severe aortic regurgitation.
    Heart. 2025 Jul 16:heartjnl-2025-325823. doi: 10.1136/heartjnl-2025-325823.
    PubMed     Abstract available
    
    
    
60. WILLIXHOFER R, Mapelli M, Baracchini N, Campana N, et al
    Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in hypertrophic cardiomyopathy.
    Heart. 2025;111:700-705.
    PubMed     Abstract available
    
    
    
61. TOMSIC A, Velders BJJ, Kawczynski MJ, Schoones JW, et al
    Representativeness of surgical controls in aortic valve replacement trials: comparison with routine surgical cohorts.
    Heart. 2025 Jul 8:heartjnl-2025-326162. doi: 10.1136/heartjnl-2025-326162.
    PubMed     Abstract available
    
    
    June 2025
62. LIM HJ, Kim K, Gwak SY, Lee HJ, et al
    Early predictors of aortic valve surgery in patients with significant bicuspid aortic regurgitation without initial surgical indication.
    Heart. 2025 Jun 20:heartjnl-2025-325892. doi: 10.1136/heartjnl-2025-325892.
    PubMed     Abstract available
    
    
    
63. FALK V
    60: 'the magic number of greatness' in minimally invasive mitral valve repair?
    Heart. 2025 Jun 20:heartjnl-2025-326326. doi: 10.1136/heartjnl-2025-326326.
    PubMed    
    
    
    
64. KASSAR M, Gercek M, Rudolph V
    Shadows and light in transcatheter mitral valve treatment: recent evidence and implications for clinical practice.
    Heart. 2025 Jun 15:heartjnl-2024-325621. doi: 10.1136/heartjnl-2024-325621.
    PubMed    
    
    
    
65. HEUTS S, Kawczynski MJ, Maesen B, Vriesendorp PA, et al
    When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation.
    Heart. 2025 Jun 10:heartjnl-2025-326208. doi: 10.1136/heartjnl-2025-326208.
    PubMed     Abstract available
    
    
    May 2025
66. SUN Y, Wang C, Li J, Luo S, et al
    Outcomes of transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis with severe calcification.
    Heart. 2025 May 10:heartjnl-2024-324697. doi: 10.1136/heartjnl-2024-324697.
    PubMed     Abstract available
    
    
    
67. NAKASE M, Draxler DF, Tomii D, Heg D, et al
    Incidence, predictors and clinical impact of upper gastrointestinal bleeding after transcatheter aortic valve replacement.
    Heart. 2025 May 10:heartjnl-2024-325359. doi: 10.1136/heartjnl-2024-325359.
    PubMed     Abstract available
    
    
    
68. HEUTS S, Hjij W, Kawczynski MJ, Olsthoorn JR, et al
    Defining centres of expertise for minimally invasive mitral valve surgery: a systematic review and volume-outcome meta-analysis.
    Heart. 2025 May 10:heartjnl-2024-325048. doi: 10.1136/heartjnl-2024-325048.
    PubMed     Abstract available
    
    
    April 2025
69. WANG C, Hamid N, Bapat V, Cavalcante JL, et al
    Incidence, predictors and outcomes of tricuspid regurgitation progression after left-sided valvular intervention.
    Heart. 2025 Apr 30:heartjnl-2024-325194. doi: 10.1136/heartjnl-2024-325194.
    PubMed     Abstract available
    
    
    
70. MCCANN GP, Newby DE, Hillis GS
    TAVI for asymptomatic aortic stenosis? More compelling outcome data are needed.
    Heart. 2025 Apr 15:heartjnl-2025-325767. doi: 10.1136/heartjnl-2025-325767.
    PubMed    
    
    
    
71. JEONG JH, Kim H, Hwang SH, Seo CO, et al
    Genotype and arrhythmic risk in patients with apical hypertrophic cardiomyopathy.
    Heart. 2025 Apr 7:heartjnl-2024-325218. doi: 10.1136/heartjnl-2024-325218.
    PubMed     Abstract available
    
    
    March 2025
72. CELMETA B, Miceli A
    Bacteraemia and infective endocarditis after transcatheter aortic valve replacement: prevention is the key.
    Heart. 2025 Mar 23:heartjnl-2024-325410. doi: 10.1136/heartjnl-2024-325410.
    PubMed    
    
    
    
73. GEERS J, Manral N, Razipour A, Park C, et al
    Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial.
    Heart. 2025 Mar 6:heartjnl-2024-324925. doi: 10.1136/heartjnl-2024-324925.
    PubMed     Abstract available
    
    
    
74. PANG L, Xia Y, Tang M, Ma M, et al
    Prevalence, spectrum and aetiology of valvular heart disease based on community echocardiographic screening transition from different altitudes in Yunnan, China.
    Heart. 2025 Mar 3:heartjnl-2024-325221. doi: 10.1136/heartjnl-2024-325221.
    PubMed     Abstract available
    
    
    February 2025
75. LEE HJ, Gwak SY, Kim K, Cho I, et al
    Factors associated with high-intensity physical activity and sudden cardiac death in hypertrophic cardiomyopathy.
    Heart. 2025;111:253-261.
    PubMed     Abstract available
    
    
    
76. LIND V, Lundman P, Friberg L, Talback M, et al
    Dysglycaemia and incident aortic stenosis: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-325150. doi: 10.1136/heartjnl-2024-325150.
    PubMed     Abstract available
    
    
    
77. TREWAREE S, Shantsila A, Lip GYH
    Pulse pressure and aortic valve peak velocity as new predictors of heart failure in patients post-myocardial infarction.
    Heart. 2025 Feb 6:heartjnl-2024-325513. doi: 10.1136/heartjnl-2024-325513.
    PubMed    
    
    
    
78. OKADA T, Kagiyama N, Kaneko T, Amano M, et al
    Echocardiographic cardiac damage classification and clinical outcomes in atrial functional mitral regurgitation.
    Heart. 2025 Feb 6:heartjnl-2024-325240. doi: 10.1136/heartjnl-2024-325240.
    PubMed     Abstract available
    
    
    
79. WU Y, Zhao J, Chen C, Huang J, et al
    Pulse pressure and aortic valve peak velocity and incident heart failure after myocardial infarction: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-324517. doi: 10.1136/heartjnl-2024-324517.
    PubMed     Abstract available
    
    
    January 2025
80. CHRISTENSEN EB, Vissing CR, Silajdzija E, Mills HL, et al
    Long-term incidence of implantable cardioverter-defibrillator therapy in patients with hypertrophic cardiomyopathy: analysis of appropriate and inappropriate interventions.
    Heart. 2025 Jan 19:heartjnl-2024-325020. doi: 10.1136/heartjnl-2024-325020.
    PubMed     Abstract available
    
    
    
81. CRAIG N, Dweck MR
    Sociodemographic treatment trends for aortic stenosis since the adoption of transcatheter aortic valve intervention.
    Heart. 2025 Jan 16:heartjnl-2024-325328. doi: 10.1136/heartjnl-2024-325328.
    PubMed    
    
    
    
82. DONAL E, Gegout L, Bourg C
    Reassessing the role of tricuspid valve surgery in the modern era.
    Heart. 2025 Jan 16:heartjnl-2024-325476. doi: 10.1136/heartjnl-2024-325476.
    PubMed    
    
    
    December 2024
83. LIU R, Fu Z, Yan Y, Xie M, et al
    New wearable cardiac acoustic monitoring technology for evaluation of subclinical leaflet thrombosis after transcatheter aortic valve replacement.
    Heart. 2024 Dec 25:heartjnl-2024-324698. doi: 10.1136/heartjnl-2024-324698.
    PubMed     Abstract available
    
    
    
84. DOEDENS A, Skarp S, Holmstrom L, Pakanen L, et al
    Genetic variants associated with cardiac hypertrophy-related sudden cardiac death and cardiovascular outcomes in a Finnish population.
    Heart. 2024;111:55-61.
    PubMed     Abstract available
    
    
    
85. PLAYFORD D, Stewart S, Harris SA, Scalia G, et al
    Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography.
    Heart. 2024 Dec 20:heartjnl-2024-324790. doi: 10.1136/heartjnl-2024-324790.
    PubMed     Abstract available
    
    
    
86. HADJI-TURDEGHAL K, Petersen JK, Graversen PL, Butt JH, et al
    Bacteraemia after transcatheter aortic valve implantation: a nationwide cohort study.
    Heart. 2024 Dec 20:heartjnl-2024-324803. doi: 10.1136/heartjnl-2024-324803.
    PubMed     Abstract available
    
    
    
87. GWAK SY, Kim K, Lee HJ, Cho I, et al
    Outcomes of tricuspid valve surgery in patients with significant tricuspid regurgitation and low to intermediate risk.
    Heart. 2024 Dec 17:heartjnl-2024-324891. doi: 10.1136/heartjnl-2024-324891.
    PubMed     Abstract available
    
    
    
88. YONES E, Gunn J, Iqbal J, Morris PD, et al
    Functional assessment of coronary artery disease in patients with severe aortic stenosis: a review.
    Heart. 2024 Dec 12:heartjnl-2024-324802. doi: 10.1136/heartjnl-2024-324802.
    PubMed     Abstract available
    
    
    
89. DIGREGORIO H, Mansoorshahi S, Carlisle SG, Tovar Pensa C, et al
    Contribution of rare chromosome 22q11.2 copy number variants to non-syndromic bicuspid aortic valve.
    Heart. 2024 Dec 10:heartjnl-2024-324669. doi: 10.1136/heartjnl-2024-324669.
    PubMed     Abstract available
    
    
    November 2024
90. SINGH A, Chalmers F, Aslam S, Bolton T, et al
    Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years.
    Heart. 2024 Nov 27:heartjnl-2024-324918. doi: 10.1136/heartjnl-2024-324918.
    PubMed     Abstract available
    
    
    
91. DONAL E, Rouleau L
    Optimising management of moderate secondary mitral regurgitation: insights into pharmacological and interventional approaches.
    Heart. 2024 Nov 7:heartjnl-2024-325097. doi: 10.1136/heartjnl-2024-325097.
    PubMed    
    
    
    
92. BJORN R, Strom JB, Lloyd G, Bhattacharyya S, et al
    Asymptomatic severe degenerative mitral regurgitation.
    Heart. 2024 Nov 7:heartjnl-2024-324739. doi: 10.1136/heartjnl-2024-324739.
    PubMed     Abstract available
    
    
    October 2024
93. SARRAZYN C, Fortuni F, Laenens D, Chua AP, et al
    Clinical and echocardiographic parameters associated with outcomes in patients with moderate secondary mitral regurgitation.
    Heart. 2024 Oct 4:heartjnl-2024-324526. doi: 10.1136/heartjnl-2024-324526.
    PubMed     Abstract available
    
    
    September 2024
94. LAI FY, Gibbison B, O'Cathain A, Akowuah E, et al
    Inequalities in access to and outcomes of cardiac surgery in England: retrospective analysis of Hospital Episode Statistics (2010-2019).
    Heart. 2024 Sep 3:heartjnl-2024-324292. doi: 10.1136/heartjnl-2024-324292.
    PubMed     Abstract available
    
    
    August 2024
95. GALLI E, Le Ven F, Coisne A, Sportouch C, et al
    Randomised study for the Optimal Treatment of symptomatic patients with low-gradient severe Aortic valve Stenosis and preserved left ventricular ejection fraction (ROTAS trial).
    Heart. 2024 Aug 28:heartjnl-2024-324224. doi: 10.1136/heartjnl-2024-324224.
    PubMed     Abstract available
    
    
    
96. JAHANGIRI M, Prendergast B
    Management of bicuspid aortic valve disease in the transcatheter aortic valve implantation era.
    Heart. 2024 Aug 7:heartjnl-2024-324054. doi: 10.1136/heartjnl-2024-324054.
    PubMed     Abstract available
    
    
    June 2024
97. RHEE TM, Kim HK
    Integrating machine learning approach to identify sleep-disordered breathing in hypertrophic cardiomyopathy.
    Heart. 2024;110:931-932.
    PubMed    
    
    
    
98. AKITA K, Kageyama S, Suzuki S, Ohno K, et al
    Machine learning-based detection of sleep-disordered breathing in hypertrophic cardiomyopathy.
    Heart. 2024;110:954-962.
    PubMed     Abstract available
    
    
    
99. KLADOU E, Kochiadakis G, Hamilos M
    Unexpected finding on imaging: an aortic valve mass.
    Heart. 2024;110:939-970.
    PubMed    
    
    
    April 2024
100. KUMAR M, Pettinato A, Ladha F, Earp JE, et al
     Sarcopenia and aortic valve disease.
     Heart. 2024 Apr 22:heartjnl-2024-324029. doi: 10.1136/heartjnl-2024-324029.
     PubMed     Abstract available
     
     
     March 2024
101. BIEROWSKI MJ, Warner ED, Edirisuriya CD
     Mitral valve dysfunction in a woman with newly diagnosed acute promyelocytic leukemia.
     Heart. 2024;110:507-540.
     PubMed    
     
     
     February 2024
102. UBBEN T, Frerker C, Fujita B, Rosenkranz S, et al
     Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
     Heart. 2024 Feb 22:heartjnl-2023-323473. doi: 10.1136/heartjnl-2023-323473.
     PubMed     Abstract available
     
     
     
103. TA S, Li J, Hsi DH, Hu R, et al
     Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.
     Heart. 2024 Feb 22:heartjnl-2023-323606. doi: 10.1136/heartjnl-2023-323606.
     PubMed     Abstract available
     
     
     January 2024
104. WACHTELL K
     Understanding the driving mechanisms of bioprosthetic valve degeneration.
     Heart. 2024;110:223-224.
     PubMed    
     
     
     
105. GUAL-CAPLLONCH F, Pericas P
     Correspondence on 'Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation' by Lemarchand et al.
     Heart. 2024 Jan 18:heartjnl-2023-323697. doi: 10.1136/heartjnl-2023-323697.
     PubMed    
     
     
     December 2023
106. PATEL KP, McKenna M, Thornton GD, Vandermolen S, et al
     Predictors of outcome in patients with moderate mixed aortic valve disease.
     Heart. 2023 Dec 26:heartjnl-2023-323321. doi: 10.1136/heartjnl-2023-323321.
     PubMed     Abstract available
     
     
     
107. DELWARDE C, Toquet C, Boureau AS, Le Ruz R, et al
     Filamin A heart valve disease as a genetic cause of inherited bicuspid and tricuspid aortic valve disease.
     Heart. 2023 Dec 26:heartjnl-2023-323491. doi: 10.1136/heartjnl-2023-323491.
     PubMed     Abstract available
     
     
     
108. PAVON AG, Guglielmo M
     Carcinoid heart disease: another step into the knowledge of a rare disease.
     Heart. 2023;110:79-80.
     PubMed    
     
     
     
109. MONDAL S, Kumar SS, Kesavan V
     Case of presyncope with mitral regurgitation.
     Heart. 2023;110:18-74.
     PubMed    
     
     
     
110. SATURI G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, et al
     Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
     Heart. 2023;110:40-48.
     PubMed     Abstract available
     
     
     
111. JANDER N, Minners J
     Towards a gender-specific and morphology-specific assessment of aortic valve stenosis severity.
     Heart. 2023 Dec 12:heartjnl-2023-323499. doi: 10.1136/heartjnl-2023-323499.
     PubMed    
     
     
     
112. SCARSINI R, Portolan L, Della Mora F, Fabroni M, et al
     Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation.
     Heart. 2023 Dec 1:heartjnl-2023-323461. doi: 10.1136/heartjnl-2023-323461.
     PubMed     Abstract available
     
     
     November 2023
113. HAZEBROEK MR, Verdonschot JAJ
     One step closer to the new frontiers of healthcare for cardiomyopathy patients.
     Heart. 2023;109:1808-1810.
     PubMed    
     
     
     
114. ANDERSON RH, Spicer DE, Sanchez-Quintana D, Macias Y, et al
     Relationship between the aortic root and the atrioventricular conduction axis.
     Heart. 2023;109:1811-1818.
     PubMed     Abstract available
     
     
     
115. ANDERSON RH, Westaby J, Sheppard MN, Cook AC, et al
     Mitral annular disjunction: a ubiquitous finding with or without mitral valvar prolapse.
     Heart. 2023 Nov 24:heartjnl-2023-323501. doi: 10.1136/heartjnl-2023-323501.
     PubMed    
     
     
     
116. HEUTS S, Gabrio A, Veenstra L, Maesen B, et al
     Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis.
     Heart. 2023 Nov 23:heartjnl-2023-323359. doi: 10.1136/heartjnl-2023-323359.
     PubMed     Abstract available
     
     
     
117. LAWIN D, Stellbrink C, Stellbrink E, Buck B, et al
     Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
     Heart. 2023;109:1778-1784.
     PubMed     Abstract available
     
     
     
118. BAROUTIDOU A, Arvanitaki A, Farmakis IT, Patsiou V, et al
     Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis.
     Heart. 2023;109:1741-1750.
     PubMed     Abstract available
     
     
     
119. KRAWCZYK-OZOG A, Batko J, Zdzierak B, Dziewierz A, et al
     Morphology of the mural and commissural atrioventricular junction of the mitral valve.
     Heart. 2023 Nov 7:heartjnl-2023-322965. doi: 10.1136/heartjnl-2023-322965.
     PubMed     Abstract available
     
     
     
120. TOMASELLI M, Badano LP, Muraru D
     Right atrial function, a mostly ignored but very valuable parameter in patients with secondary tricuspid regurgitation.
     Heart. 2023 Nov 6:heartjnl-2023-323426. doi: 10.1136/heartjnl-2023-323426.
     PubMed    
     
     
     
121. BOTEZATU SB, Yu X, Meah MN, Williams MC, et al
     Aortic valve perivascular adipose tissue computed tomography attenuation in patients with aortic stenosis.
     Heart. 2023 Nov 2:heartjnl-2023-323217. doi: 10.1136/heartjnl-2023-323217.
     PubMed     Abstract available
     
     
     October 2023
122. GALLOO X, Fortuni F, Meucci MC, Butcher SC, et al
     Association of right atrial strain and long-term outcome in severe secondary tricuspid regurgitation.
     Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
     PubMed     Abstract available
     
     
     
123. YE Z, Clavel MA, Foley TA, Pibarot P, et al
     Computed tomography calcium scoring in aortic stenosis: bicuspid versus tricuspid morphology.
     Heart. 2023 Oct 30:heartjnl-2023-323281. doi: 10.1136/heartjnl-2023-323281.
     PubMed     Abstract available
     
     
     
124. CHA MJ, Lee SA, Cho MS, Nam GB, et al
     Reduction of moderate to severe tricuspid regurgitation after catheter ablation for atrial fibrillation.
     Heart. 2023 Oct 25:heartjnl-2023-323244. doi: 10.1136/heartjnl-2023-323244.
     PubMed     Abstract available
     
     
     
125. LEMARCHAND L, Auffret V, Le Breton H, Bedossa M, et al
     Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation.
     Heart. 2023 Oct 12:heartjnl-2023-322893. doi: 10.1136/heartjnl-2023-322893.
     PubMed     Abstract available
     
     
     
126. OTTO CM, Bartkowiak J, Hahn RT
     Right atrial pressure, not Doppler jet velocity, is the problem in estimating pulmonary pressure when tricuspid regurgitation is severe.
     Heart. 2023 Oct 12:heartjnl-2023-323230. doi: 10.1136/heartjnl-2023-323230.
     PubMed    
     
     
     
127. VEERARAGHAVAN S, Kidambi BR
     Sudden-onset breathlessness in a middle-aged man.
     Heart. 2023;109:1601-1650.
     PubMed    
     
     
     
128. DEMAL TJ, Conradi L
     Management of valve dysfunction in patients with mitral annular calcification.
     Heart. 2023;109:1639-1646.
     PubMed    
     
     
     September 2023
129. OTTO CM
     Heartbeat: a trend over the past 20 years towards decreased aortic stenosis mortality in patients aged 80 years or older.
     Heart. 2023;109:1419-1421.
     PubMed    
     
     
     
130. MICHELENA HI, Anand V, Enriquez-Sarano M, Pellikka PA, et al
     Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Ratwatte et al.
     Heart. 2023 Sep 1:heartjnl-2023-323347. doi: 10.1136/heartjnl-2023-323347.
     PubMed    
     
     
     
131. RATWATTE S, Celermajer DS
     Response to: Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Michelena et al.
     Heart. 2023 Sep 1:heartjnl-2023-323348. doi: 10.1136/heartjnl-2023-323348.
     PubMed    
     
     
     August 2023
132. FARINA JM, Chao CJ, Pereyra M, Roarke M, et al
     Role of lipoprotein(a) concentrations in bioprosthetic aortic valve degeneration.
     Heart. 2023 Aug 29:heartjnl-2023-322987. doi: 10.1136/heartjnl-2023-322987.
     PubMed     Abstract available
     
     
     
133. BARNES C, Sharma H, Gamble J, Dawkins S, et al
     Management of secondary mitral regurgitation: from drugs to devices.
     Heart. 2023 Aug 22:heartjnl-2022-322001. doi: 10.1136/heartjnl-2022-322001.
     PubMed     Abstract available
     
     
     
134. JANG MH, Ahn JM, Kang DY, Kim KW, et al
     Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement.
     Heart. 2023 Aug 16:heartjnl-2023-322946. doi: 10.1136/heartjnl-2023-322946.
     PubMed     Abstract available
     
     
     
135. XU Z, Gong C, Chen Y
     Patient in their 40s with unexplained myocardial hypertrophy.
     Heart. 2023;109:1280-1340.
     PubMed    
     
     
     
136. OTTO CM
     Heartbeat: elevated pulmonary pressures in adults with aortic valve disease.
     Heart. 2023;109:1263-1265.
     PubMed    
     
     
     
137. KUSUNOSE K, Ikemiyagi H
     Prognostic implications of pulmonary vascular resistance in transcatheter aortic valve implantation.
     Heart. 2023 Aug 8:heartjnl-2023-323094. doi: 10.1136/heartjnl-2023-323094.
     PubMed    
     
     
     July 2023
138. LIEBENBERG J, Doubell A, Steyn J, Herbst P, et al
     Exploring the mechanisms responsible for reduced systolic function in high-gradient aortic stenosis.
     Heart. 2023 Jul 24:heartjnl-2023-322727. doi: 10.1136/heartjnl-2023-322727.
     PubMed     Abstract available
     
     
     
139. MASSERA D, Bartz TM, Biggs ML, Sotoodehnia N, et al
     Traditional and novel risk factors for incident aortic stenosis in community-dwelling older adults.
     Heart. 2023 Jul 18:heartjnl-2023-322709. doi: 10.1136/heartjnl-2023-322709.
     PubMed     Abstract available
     
     
     
140. MARTINSSON A, Torngren C, Nielsen SJ, Pan E, et al
     Renin-angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis.
     Heart. 2023 Jul 17:heartjnl-2023-322922. doi: 10.1136/heartjnl-2023-322922.
     PubMed     Abstract available
     
     
     
141. LUMISH HS, Liang LW, Hasegawa K, Maurer MS, et al
     Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
     Heart. 2023 Jul 14:heartjnl-2023-322644. doi: 10.1136/heartjnl-2023-322644.
     PubMed     Abstract available
     
     
     
142. AFOKE J, Camacho E, Bagameri G
     Recurrent ventricular arrhythmia after aortic root replacement and mitral valve repair.
     Heart. 2023;109:1145-1192.
     PubMed    
     
     
     
143. FARRANT J, Dodd S, Vaughan C, Reid A, et al
     Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.
     Heart. 2023;109:1175-1182.
     PubMed     Abstract available
     
     
     
144. CARDAIOLI F, Nai Fovino L, Fabris T, Masiero G, et al
     Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation.
     Heart. 2023 Jul 6:heartjnl-2023-322881. doi: 10.1136/heartjnl-2023-322881.
     PubMed     Abstract available
     
     
     
145. HOHMANN C, Pfister R, Frerker C, Beckmann A, et al
     Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation.
     Heart. 2023 Jul 5:heartjnl-2023-322548. doi: 10.1136/heartjnl-2023-322548.
     PubMed     Abstract available
     
     
     June 2023
146. NGUYEN DD, Arnold SV
     Impact of frailty on disease-specific health status in cardiovascular disease.
     Heart. 2023;109:977-983.
     PubMed     Abstract available
     
     
     
147. COURTNEY WA, Schultz CJ, Hillis GS
     Aortic valve calcification and outcomes in severe aortic stenosis.
     Heart. 2023 Jun 8:heartjnl-2023-322771. doi: 10.1136/heartjnl-2023-322771.
     PubMed    
     
     
     
148. CHOI Y, Ahn JM, Yang DH, Koo HJ, et al
     Clinical outcomes after aortic valve replacement with severe stenosis of trileaflet aortic valve and low valve calcium score.
     Heart. 2023 Jun 8:heartjnl-2023-322435. doi: 10.1136/heartjnl-2023-322435.
     PubMed     Abstract available
     
     
     
149. SAN ROMAN JA, Ybarra-Falcon C, Garcia-Gomez M, Ramos N, et al
     Recurrence of syncope after valve replacement in severe aortic stenosis.
     Heart. 2023 Jun 7:heartjnl-2023-322859. doi: 10.1136/heartjnl-2023-322859.
     PubMed     Abstract available
     
     
     May 2023
150. PISLARU SV, Nkomo VT
     Subannular repair for secondary mitral regurgitation: a step towards peaceful conversations.
     Heart. 2023 May 31:heartjnl-2023-322609. doi: 10.1136/heartjnl-2023-322609.
     PubMed    
     
     
     
151. NIENABER CA, Yuan X, Nienaber SA
     Aortic stenosis may not be fatal anymore in wealthy societies: but what about the rest of the world?
     Heart. 2023 May 26:heartjnl-2023-322737. doi: 10.1136/heartjnl-2023-322737.
     PubMed    
     
     
     
152. SEVILLA T, Rojas G, Gonzalez-Bartol E, Candela J, et al
     Magnetic resonance analysis of ventricular volumes in bicuspid and trileaflet aortic regurgitation.
     Heart. 2023 May 25:heartjnl-2023-322519. doi: 10.1136/heartjnl-2023-322519.
     PubMed     Abstract available
     
     
     
153. ANGUITA-GAMEZ M, Giraldo MA, Nombela-Franco L, Eixeres Esteve A, et al
     Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation.
     Heart. 2023 May 22:heartjnl-2022-322067. doi: 10.1136/heartjnl-2022-322067.
     PubMed     Abstract available
     
     
     
154. HIBINO M, Pandey AK, Hibino H, Verma R, et al
     Mortality trends of aortic stenosis in high-income countries from 2000 to 2020.
     Heart. 2023 May 19:heartjnl-2023-322397. doi: 10.1136/heartjnl-2023-322397.
     PubMed     Abstract available
     
     
     
155. OTTO CM
     Heartbeat: Choice of aortic valve intervention in younger adults.
     Heart. 2023;109:807-809.
     PubMed    
     
     
     
156. SHAH BN
     National Institute for Health and Care Excellence (NICE) guidance on heart valve disease.
     Heart. 2023;109:817-822.
     PubMed     Abstract available
     
     
     
157. VAN HOOF L, Lamberigts M, Noe D, El-Hamamsy I, et al
     Matched comparison between external aortic root support and valve-sparing root replacement.
     Heart. 2023;109:832-838.
     PubMed     Abstract available
     
     
     
158. NUNES MCP, Barbosa JAA, Mocumbi A
     Refining morphological echocardiographic criteria to improve early detection of rheumatic heart disease.
     Heart. 2023 May 12:heartjnl-2022-322325. doi: 10.1136/heartjnl-2022-322325.
     PubMed    
     
     
     
159. OH JK, Shen M, Guzzetti E, Tastet L, et al
     Effect of race on pressure recovery adjustment for prevention of aortic stenosis grading discordance.
     Heart. 2023 May 5:heartjnl-2023-322586. doi: 10.1136/heartjnl-2023-322586.
     PubMed     Abstract available
     
     
     
160. LEEDY D, Elison DM, Farias F, Cheng R, et al
     Transcatheter aortic valve intervention in patients with cancer.
     Heart. 2023 May 5:heartjnl-2022-321396. doi: 10.1136/heartjnl-2022-321396.
     PubMed     Abstract available
     
     
     
161. GALIAN-GAY L, Pijuan-Domenech A, Cantalapiedra-Romero J, Serrano B, et al
     Pregnancy-related aortic complications in women with bicuspid aortic valve.
     Heart. 2023 May 5:heartjnl-2022-322328. doi: 10.1136/heartjnl-2022-322328.
     PubMed     Abstract available
     
     
     
162. SAN ROMAN JA
     Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Paolisso et al.
     Heart. 2023 May 3:heartjnl-2023-322844. doi: 10.1136/heartjnl-2023-322844.
     PubMed    
     
     
     
163. VAN CAMP G
     Response to: Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Jose Alberto San Roman.
     Heart. 2023 May 3:heartjnl-2023-322845. doi: 10.1136/heartjnl-2023-322845.
     PubMed    
     
     
     April 2023
164. HUNTER LD, Doubell AF, Pecoraro AJK, Monaghan M, et al
     Morpho-mechanistic screening criteria for the echocardiographic detection of rheumatic heart disease.
     Heart. 2023 Apr 28:heartjnl-2022-322192. doi: 10.1136/heartjnl-2022-322192.
     PubMed     Abstract available
     
     
     
165. OTTO CM
     Heartbeat: sudden cardiac death risk in patients with hypertrophic cardiomyopathy.
     Heart. 2023;109:725-727.
     PubMed    
     
     
     
166. RUBIS P
     Low-normal systolic function and hypertrophic cardiomyopathy.
     Heart. 2023;109:732-733.
     PubMed    
     
     
     
167. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
     Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
     Heart. 2023;109:771-778.
     PubMed     Abstract available
     
     
     
168. CRAMARIUC D, Urheim S
     Pulmonary hypertension in significant aortic valve disease: a dive into real-world data.
     Heart. 2023 Apr 24:heartjnl-2023-322495. doi: 10.1136/heartjnl-2023-322495.
     PubMed    
     
     
     
169. RATWATTE S, Playford D, Stewart S, Strange G, et al
     Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes.
     Heart. 2023 Apr 3:heartjnl-2022-322187. doi: 10.1136/heartjnl-2022-322187.
     PubMed     Abstract available
     
     
     
170. RATWATTE S, Stewart S, Strange G, Playford D, et al
     Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes.
     Heart. 2023 Apr 3:heartjnl-2022-322184. doi: 10.1136/heartjnl-2022-322184.
     PubMed     Abstract available
     
     
     March 2023
171. PAUSCH J, Harmel E, Reichenspurner H, Kempfert J, et al
     Subannular repair in secondary mitral regurgitation with restricted leaflet motion during systole.
     Heart. 2023 Mar 27:heartjnl-2022-322239. doi: 10.1136/heartjnl-2022-322239.
     PubMed     Abstract available
     
     
     
172. OTTO CM
     Heartbeat: heart valve clinics improve outcomes in patients with aortic valve stenosis.
     Heart. 2023;109:573-575.
     PubMed    
     
     
     
173. BISWAS A, Shukla A, Kothari SS
     Typical effort angina in a tall adult.
     Heart. 2023;109:605-650.
     PubMed    
     
     
     
174. GARTSHTEYN Y, Bhave N, Joseph MS, Askanase A, et al
     Inflammatory and thrombotic valvulopathies in autoimmune disease.
     Heart. 2023;109:583-588.
     PubMed     Abstract available
     
     
     
175. MARON MS, Rowin E, Spirito P, Maron BJ, et al
     Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
     Heart. 2023;109:589-594.
     PubMed     Abstract available
     
     
     
176. VELDERS BJJ, Vriesendorp MD, De Lind Van Wijngaarden RAF, Rao V, et al
     Perioperative care differences of surgical aortic valve replacement between North America and Europe.
     Heart. 2023 Mar 24:heartjnl-2023-322350. doi: 10.1136/heartjnl-2023-322350.
     PubMed     Abstract available
     
     
     
177. GEERS J, Bing R
     Computed tomographic imaging of patients with native and prosthetic aortic valve stenosis.
     Heart. 2023 Mar 22:heartjnl-2022-321660. doi: 10.1136/heartjnl-2022-321660.
     PubMed    
     
     
     
178. BEYER SE, Secemsky EA, Khabbaz K, Carroll BJ, et al
     Elective ascending aortic aneurysm repair outcomes in a nationwide US cohort.
     Heart. 2023 Mar 16:heartjnl-2022-322033. doi: 10.1136/heartjnl-2022-322033.
     PubMed     Abstract available
     
     
     
179. ALI Z, Flynn AW
     Severe aortic stenosis and the need for the right treatment, in the right place, at the right time.
     Heart. 2023 Mar 13:heartjnl-2022-322195. doi: 10.1136/heartjnl-2022-322195.
     PubMed    
     
     
     
180. OTTO CM
     Heartbeat: clinical practice patterns for valve intervention in adults with aortic stenosis.
     Heart. 2023;109:495-497.
     PubMed    
     
     
     February 2023
181. KRIEGER EV, Burke CR, McCabe JM
     Sometimes mechanical, never routine: aortic valve replacement in young adults.
     Heart. 2023 Feb 27:heartjnl-2022-322150. doi: 10.1136/heartjnl-2022-322150.
     PubMed    
     
     
     
182. STOICA S, Beard C, Takkenberg JJM, Mokhles MM, et al
     Formal consensus study on surgery to replace the aortic valve in adults aged 18-60 years.
     Heart. 2023 Feb 27:heartjnl-2022-321740. doi: 10.1136/heartjnl-2022-321740.
     PubMed     Abstract available
     
     
     
183. DREYFUS J, Bohbot Y, Coisne A, Lavie-Badie Y, et al
     Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery.
     Heart. 2023 Feb 24:heartjnl-2022-322167. doi: 10.1136/heartjnl-2022-322167.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum